These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28124213)

  • 1. Betulinic Acid Induces Apoptosis in Differentiated PC12 Cells Via ROS-Mediated Mitochondrial Pathway.
    Wang X; Lu X; Zhu R; Zhang K; Li S; Chen Z; Li L
    Neurochem Res; 2017 Apr; 42(4):1130-1140. PubMed ID: 28124213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self assembled nano fibers of betulinic acid: A selective inducer for ROS/TNF-alpha pathway mediated leukemic cell death.
    Dash SK; Chattopadhyay S; Dash SS; Tripathy S; Das B; Mahapatra SK; Bag BG; Karmakar P; Roy S
    Bioorg Chem; 2015 Dec; 63():85-100. PubMed ID: 26469741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Betulinic acid induces apoptosis by regulating PI3K/Akt signaling and mitochondrial pathways in human cervical cancer cells.
    Xu T; Pang Q; Wang Y; Yan X
    Int J Mol Med; 2017 Dec; 40(6):1669-1678. PubMed ID: 29039440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Betulinic acid inhibits the proliferation of human laryngeal carcinoma cells through reactive oxygen species-mediate mitochondrial apoptotic pathway.
    Zhang H; Zhou M; Ye C; Qin J; Lu X; Wang C; Wang X; Jin X
    Toxicol In Vitro; 2024 Mar; 95():105756. PubMed ID: 38061603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Betulinic acid induces apoptosis and inhibits metastasis of human renal carcinoma cells in vitro and in vivo.
    Yang C; Li Y; Fu L; Jiang T; Meng F
    J Cell Biochem; 2018 Nov; 119(10):8611-8622. PubMed ID: 29923216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Betulinic Acid Cytotoxicity and Mitochondrial Metabolism Impairment in a Human Melanoma Cell Line.
    Coricovac D; Dehelean CA; Pinzaru I; Mioc A; Aburel OM; Macasoi I; Draghici GA; Petean C; Soica C; Boruga M; Vlaicu B; Muntean MD
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betulinic Acid Inhibits Cell Proliferation in Human Oral Squamous Cell Carcinoma via Modulating ROS-Regulated p53 Signaling.
    Shen H; Liu L; Yang Y; Xun W; Wei K; Zeng G
    Oncol Res; 2017 Aug; 25(7):1141-1152. PubMed ID: 28109089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Betulinic acid induces DNA damage and apoptosis in SiHa cells.
    Goswami P; Paul S; Banerjee R; Kundu R; Mukherjee A
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Apr; 828():1-9. PubMed ID: 29555058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo protective effect of betulinic acid on dexamethasone induced thymocyte apoptosis by reducing oxidative stress.
    Yi J; Zhu R; Wu J; Wu J; Xia W; Zhu L; Jiang W; Xiang S; Tan Z
    Pharmacol Rep; 2016 Feb; 68(1):95-100. PubMed ID: 26721359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Betulinic acid induces apoptosis of HeLa cells via ROS-dependent ER stress and autophagy in vitro and in vivo.
    Chen P; Zhang X; Fang Q; Zhao Z; Lin C; Zhou Y; Liu F; Zhu C; Wu A
    J Nat Med; 2024 Jun; 78(3):677-692. PubMed ID: 38403724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors.
    Fulda S; Friesen C; Los M; Scaffidi C; Mier W; Benedict M; Nuñez G; Krammer PH; Peter ME; Debatin KM
    Cancer Res; 1997 Nov; 57(21):4956-64. PubMed ID: 9354463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betulinic Acid Restricts Human Bladder Cancer Cell Proliferation In Vitro by Inducing Caspase-Dependent Cell Death and Cell Cycle Arrest, and Decreasing Metastatic Potential.
    Kim SY; Hwangbo H; Kim MY; Ji SY; Kim DH; Lee H; Kim GY; Moon SK; Leem SH; Yun SJ; Kim WJ; Cheong J; Park C; Choi YH
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33806566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Betulinic acid induces apoptosis and inhibits metastasis of human colorectal cancer cells in vitro and in vivo.
    Zeng A; Hua H; Liu L; Zhao J
    Bioorg Med Chem; 2019 Jun; 27(12):2546-2552. PubMed ID: 30910472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betulinic acid induces apoptosis and inhibits hedgehog signalling in rhabdomyosarcoma.
    Eichenmüller M; Hemmerlein B; von Schweinitz D; Kappler R
    Br J Cancer; 2010 Jun; 103(1):43-51. PubMed ID: 20517313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Betulinic acid induces apoptosis in skin cancer cells and differentiation in normal human keratinocytes.
    Galgon T; Wohlrab W; Dräger B
    Exp Dermatol; 2005 Oct; 14(10):736-43. PubMed ID: 16176281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation.
    Tan Y; Yu R; Pezzuto JM
    Clin Cancer Res; 2003 Jul; 9(7):2866-75. PubMed ID: 12855667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cell cycle arrest and apoptosis by betulinic acid-rich fraction from Dillenia suffruticosa root in MCF-7 cells involved p53/p21 and mitochondrial signalling pathway.
    Foo JB; Saiful Yazan L; Tor YS; Wibowo A; Ismail N; How CW; Armania N; Loh SP; Ismail IS; Cheah YK; Abdullah R
    J Ethnopharmacol; 2015 May; 166():270-8. PubMed ID: 25797115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53-p66(shc)/miR-21-Sod2 signaling is critical for the inhibitory effect of betulinic acid on hepatocellular carcinoma.
    Yang J; Qiu B; Li X; Zhang H; Liu W
    Toxicol Lett; 2015 Nov; 238(3):1-10. PubMed ID: 26222667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Betulinic acid promotes TRAIL function on liver cancer progression inhibition through p53/Caspase-3 signaling activation.
    Xu Y; Li J; Li QJ; Feng YL; Pan F
    Biomed Pharmacother; 2017 Apr; 88():349-358. PubMed ID: 28119237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betulinic acid-induced apoptosis in leukemia cells.
    Ehrhardt H; Fulda S; Führer M; Debatin KM; Jeremias I
    Leukemia; 2004 Aug; 18(8):1406-12. PubMed ID: 15201849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.